Researcher
Patrizia Agostinis
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Cell death, Cell signalling, Cancer therapy
Affiliations
- Laboratory of Cell Death Research & Therapy (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2012 → Today - Agostinis Lab (Research group)
Responsible
From1 Mar 2019 → Today - Laboratory of Cell Death Research & Therapy (VIB-KU Leuven) (Division)
Member
From1 Oct 2007 → Today
Projects
51 - 56 of 56
- AKT/PKB signaling pathways in different stages of skin cancer: prognostic and therapeutical implications.From1 Jan 2009 → 31 Dec 2012Funding: FWO research project (including WEAVE projects)
- Signal transduction in ER stress: the role of the 'Unfolded protein response' in anticancer therapy.From1 Jan 2009 → 31 Dec 2012Funding: FWO research project (including WEAVE projects)
- Damage-associated Molecular Patterns: revealing the molecular communication between dying cancer cells and the immune systemFrom3 Nov 2008 → 25 Sep 2012Funding: Own budget, for example: patrimony, inscription fees, gifts
- Unrafeling the role of autophagy in cutaneous malignant melanoma.From1 Oct 2008 → 2 Jan 2014Funding: IWT personal funding - strategic basic research grants, BOF - Doctoral projects
- Hypoxia-driven signaling pathways in the progression of cutaneous malignant melanoma.From1 Jan 2008 → 31 Dec 2011Funding: FWO research project (including WEAVE projects)
- Understanding non-genetic processes remodelling the tumor ecosystem, cancer cell death and immune escape mechanismsFrom1 Oct 2000 → TodayFunding: BOF - ZAP BOF mandates
Publications
1 - 10 of 239
- Tumor endothelial cell autophagy is a key vascular-immune checkpoint in melanoma(2024)
Authors: Jelle Verhoeven, Patrizia Agostinis, Madhur Agrawal, Sandra Nuyts
- An autophagy program that promotes T cell egress from the lymph node controls responses to immune checkpoint blockade.(2024)
Authors: Apostolis Nikolakopoulos, Francesca Bosisio, Gabriele Bergers, Colinda Scheele, Patrizia Agostinis
Pages: 114020 - SECRETED APOE REWIRES MELANOMA CELL STATE VULNERABILITY TO FERROPTOSIS(2024)
Authors: Sanket More, Patrizia Agostinis
- Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs.(2024)
Authors: Yingli Zhu, Yoke Chin Chai, Patrizia Agostinis, Johan Swinnen
Pages: 6 - Decoding immunogenic cell death from a dendritic cell perspective(2024)
Authors: Patrizia Agostinis
Pages: 350 - 370 - Tumor endothelial cell autophagy is a key vascular-immune checkpoint in melanoma(2023)
Authors: Francesca Rizzollo, Johan Van Weyenbergh, Oliver Bechter, Francesca Bosisio, Chris Marine, Diether Lambrechts, Gabriele Bergers, Patrizia Agostinis
- REVERSE TRANSLATIONAL DESIGNING OF THE NEXT-GENERATION ANTICANCER DC VACCINATIONS: Mechanisms and beyond(2023)
Authors: Jenny Sprooten, Abhishek Garg, Susan Schlenner, Patrizia Agostinis
- Cellular and molecular features related to exceptional therapy response and extreme long-term survival in glioblastoma(2023)
Authors: Maxime Vanmechelen, Paul Clement, Jean-françois Daisne, Isabelle Vanden Bempt, Raf Sciot, Abhishek Garg, Patrizia Agostinis, Frederik De Smet, Steven De Vleeschouwer
Pages: 11107 - 11126 - Apoptotic cell death in disease-Current understanding of the NCCD 2023(2023)
Authors: Patrizia Agostinis, Bart De Strooper, Abhishek Garg, Chris Marine
Pages: 1097 - 1154 - Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy(2023)
Authors: Ali Talebi, Vincent de Laat, Xander Spotbeen, Jonas Dehairs, Ginevra Doglioni, David Nittner, Tania Roskams, Patrizia Agostinis, Oliver Bechter, Veerle Boecxstaens, et al.